CDCP1 antibodies and antibody drug conjugates
US12371507B2 · kind B2 · utility
0Cited by
0References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 7, 2019 |
| Grant date | Jul 29, 2025 |
| Priority date | — |
| Expiry date | Aug 12, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/915
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides materials and methods for CUB domain-containing protein 1 (CDCP1)-targeted therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.